Abstract
We describe the case of a child affected by acute lymphoblastic leukaemia who received adoptive immunotherapy after cord blood transplantation (CBT). The patient, transplanted in second relapse resistant to chemotherapy, still showed lung and costal leukaemic nodular lesions 2 months after CBT. For this reason, three infusions of donor peripheral blood leukocytes 1 × 107/kg each were administered on days +60, +80 and +100. The procedure was well tolerated by both patient and donor, and a complete disappearance of the lung lesions was documented 2 months after the last infusion. The patient remains in continuous complete haematological remission 13 months after CBT. This experience suggests that adoptive immunotherapy may be safely employed after CBT in order to increase the contribution of immune-mediated anti-leukaemia effect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Locatelli, F., Comoli, P., Giorgiani, G. et al. Infusion of donor-derived peripheral blood leukocytes after transplantation of cord blood progenitor cells can increase the graft-versus-leukaemia effect. Leukemia 11, 729–731 (1997). https://doi.org/10.1038/sj.leu.2400644
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400644
Keywords
This article is cited by
-
Donor leukocyte infusions in acute lymphocytic leukemia
Bone Marrow Transplantation (2000)
-
Successful treatment of relapsed CML after cord blood transplantation with donor leukocyte infusion IL-2 and IFNα
Bone Marrow Transplantation (2000)